IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Ganga Pharmaceuticals IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 1.54 Cr. The company is based in Mumbai and caters to Pharmaceutical - Ayurvedic sector. First Overseas Capital is the merchant banker of Ganga Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th September 2015.
Ganga Pharmaceuticals IPO open date is 29th January 2016 and close date is 9th February 2016. IPO Allotment Date is 30th November -0001 and Listing date is 22nd February 2016.
IPO
Size:
₹ 1.54 Cr.
Avg IPO Size (Sector Based)
: ₹
24.36 cr.
Sector: Pharmaceutical - Ayurvedic
SME
IPO so far:
3
Merchant Banker:
First Overseas
SME
IPO by BRLM so far:
51
City:
Mumbai
SME
IPO so far:
288
Revenue (annualised):
₹
2.58
cr. 
PE
Ratio:
65.00x
Average Sector PE Ratio: 12.54x
Ganga Pharmaceuticals IPO size is ₹ 1.54 Cr. with IPO price of ₹ 15.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
First Overseas Capital Limited is the book-running lead manager of the Ganga Pharmaceuticals IPO. Kfin Technologies Limited is the Registrar and Market Maker is Alacrity Securities Limited for Ganga Pharmaceuticals IPO.
Ganga Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Ganga Pharmaceuticals IPO, based in Mumbai, operates in the Pharmaceutical - Ayurvedic sector with a focus on marketing distribution of Bulk Ayurvedic Medicines. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Ganga Pharmaceuticals IPO size is ₹ 1.54 Cr. with fresh issue size of ₹ 2 and Offer for sale being ₹ Nil
The IPO allotment date for Ganga Pharmaceuticals IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Ganga Pharmaceuticals IPO allotment status on the registrars website, Kfin Technologies Limited . Ganga Pharmaceuticals IPO refund dates are 30th November -0001.
Ganga Pharmaceuticals IPO is expected to be listed on 22nd February 2016.
The upper price band for the Ganga Pharmaceuticals IPO is set at ₹ 15.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Ganga Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Ganga Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 9th February 2016. After submission, funds are blocked until the basis of allotment of Ganga Pharmaceuticals IPO is finalised.
The merchant banker for Ganga Pharmaceuticals IPO is First Overseas Capital Limited . First Overseas Capital Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Ganga Pharmaceuticals IPO RHP for further details.
The registrar for Ganga Pharmaceuticals IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Ganga Pharmaceuticals IPO through their official website or helpline.
Ganga Pharmaceuticals IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1.54 Cr.
Avg IPO Size (Sector Based)
:
₹ 24.36 Cr.
Sector: Pharmaceutical - Ayurvedic
SME
IPO so far:
3
Merchant Banker:
First Overseas
SME
IPO by BRLM so far:
51
City:
Mumbai
SME
IPO so far:
288
Revenue (annualised):
₹ 2.58 cr.
PE
Ratio:
65.00x
Average Sector PE Ratio: 12.54x
Ganga Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Ganga Pharmaceuticals Financial Review Page
Merchant Banker(s) of Ganga Pharmaceuticals IPO: First Overseas Capital Limited
Ganga Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ganga Pharmaceuticals IPO listed at a listing price of 14.50 against the offer price of 15.00.
The current market price of Ganga Pharmaceuticals is 14.80.
Why Us?
